CLOVER HEALTH INVESTMENTS, CORP.CLOVEarnings & Financial Report
Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.
Revenue
$331.0M
Gross Profit
$81.2M
Operating Profit
$-8.8M
Net Profit
$-9.2M
Gross Margin
24.5%
Operating Margin
-2.7%
Net Margin
-2.8%
YoY Growth
8.2%
CLOVER HEALTH INVESTMENTS, CORP. Q3 FY2024 Financial Summary
CLOVER HEALTH INVESTMENTS, CORP. reported revenue of $331.0M (up 8.2% YoY) for Q3 FY2024, with a net profit of $-9.2M (up 77.9% YoY) (-2.8% margin). Cost of goods sold was $249.8M, operating expenses totaled $90.0M.
Key Financial Metrics
| Total Revenue | $331.0M |
|---|---|
| Net Profit | $-9.2M |
| Gross Margin | 24.5% |
| Operating Margin | -2.7% |
| Report Period | Q3 FY2024 |
CLOVER HEALTH INVESTMENTS, CORP. Annual Revenue by Year
CLOVER HEALTH INVESTMENTS, CORP. annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.9B).
| Year | Annual Revenue |
|---|---|
| 2025 | $1.9B |
| 2024 | $1.4B |
| 2023 | $1.3B |
| 2022 | $1.1B |
CLOVER HEALTH INVESTMENTS, CORP. Quarterly Revenue & Net Profit History
CLOVER HEALTH INVESTMENTS, CORP. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $487.7M | +44.7% | $-49.3M | -10.1% |
| Q3 FY2025 | $496.6M | +50.1% | $-24.4M | -4.9% |
| Q2 FY2025 | $477.6M | +34.1% | $-10.6M | -2.2% |
| Q1 FY2025 | $462.3M | +33.3% | $-1.3M | -0.3% |
| Q4 FY2024 | $337.0M | +7.9% | $-22.1M | -6.6% |
| Q3 FY2024 | $331.0M | +8.2% | $-9.2M | -2.8% |
| Q2 FY2024 | $356.3M | +11.3% | $7.4M | 2.1% |
| Q1 FY2024 | $346.9M | +7.7% | $-19.2M | -5.5% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $346.9M | $356.3M | $331.0M | $337.0M | $462.3M | $477.6M | $496.6M | $487.7M |
| YoY Growth | 7.7% | 11.3% | 8.2% | 7.9% | 33.3% | 34.1% | 50.1% | 44.7% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $671.8M | $674.2M | $653.0M | $580.7M | $583.7M | $575.0M | $559.7M | $541.0M |
| Liabilities | $379.3M | $349.3M | $310.8M | $239.6M | $247.6M | $230.8M | $218.7M | $232.3M |
| Equity | $292.5M | $324.9M | $342.2M | $341.1M | $336.1M | $344.2M | $340.9M | $308.7M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $25.9M | $44.8M | $50.0M | $34.8M | $-16.3M | $5.4M | $12.1M | $-66.9M |